SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-034081
Filing Date
2023-12-11
Accepted
2023-12-11 16:32:03
Documents
14
Period of Report
2023-12-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20231208_8k.htm   iXBRL 8-K 28397
2 EXHIBIT 10.3 ex_604715.htm EX-10.3 15050
  Complete submission text file 0001437749-23-034081.txt   178005

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nby-20231207.xsd EX-101.SCH 3402
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20231207_def.xml EX-101.DEF 11422
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20231207_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20231207_pre.xml EX-101.PRE 11582
8 EXTRACTED XBRL INSTANCE DOCUMENT nby20231208_8k_htm.xml XML 2565
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 231478577
SIC: 2834 Pharmaceutical Preparations